Exon Deletions and Duplications in BRCA1 Detected by Semiquantitative PCR
- 19 March 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing
- Vol. 4 (1) , 49-54
- https://doi.org/10.1089/109065700316471
Abstract
Large rearrangements have recently been identified in the BRCA1 gene. Inclusion of a method for identifying such rearrangements should now be a prerequisite for providing a comprehensive mutation detection strategy. We have developed a semiquantitative PCR-based fluorescent assay for the detection of previously identified deletions. This method avoids the need for long PCR or Southern blotting and is suitable for large-scale epidemiological studies. The assay was used to screen 44 high-risk families within the U.K. Yorkshire Health Region. No deletions were detected, but five cases (11%) with an apparent duplication of exon 13 in BRCA1 were identified. The presence of this mutation was confirmed by long PCR. Further developments include extending the assay to include all exons of BRCA1.Keywords
This publication has 6 references indexed in Scilit:
- Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations [published erratum appears in Hum Mol Genet 1999 Apr;8(4):717-9]Human Molecular Genetics, 1999
- An Alu-Mediated 6-kb Duplication in the BRCA1 Gene: A New Founder Mutation?American Journal of Human Genetics, 1999
- BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsNature Genetics, 1997
- Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer familyHuman Molecular Genetics, 1997
- Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.Journal of Medical Genetics, 1996
- Mutations and Polymorphisms in the familial early-onset breast cancer (BRCA1) geneHuman Mutation, 1996